Show simple item record

dc.contributor.authorBorowczyk, Kamila
dc.contributor.authorPiechocka, Justyna
dc.contributor.authorGłowacki, Rafał
dc.contributor.authorDhar, Indu
dc.contributor.authorMidttun, Øivind
dc.contributor.authorTell, Grethe S.
dc.contributor.authorUeland, Per Magne
dc.contributor.authorNygård, Ottar
dc.contributor.authorJakubowski, Hieronim
dc.date.accessioned2022-07-25T13:07:40Z
dc.date.available2022-07-25T13:07:40Z
dc.date.created2018-10-18T09:52:11Z
dc.date.issued2018
dc.identifier.citationJournal of Internal Medicine. 2018, 285 (2), 232-244.
dc.identifier.issn0954-6820
dc.identifier.urihttps://hdl.handle.net/11250/3008240
dc.language.isoeng
dc.relation.urihttps://onlinelibrary.wiley.com/doi/full/10.1111/joim.12834
dc.titleUrinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber232-244
dc.source.volume285
dc.source.journalJournal of Internal Medicine
dc.source.issue2
dc.identifier.doi10.1111/joim.12834
dc.identifier.cristin1621281
cristin.unitcode7502,3,0,0
cristin.unitnamePsykisk og fysisk helse
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record